Companies: 10,795·Total market cap: $144.5T
Spectrum Pharmaceuticals, Inc.

Spectrum Pharmaceuticals, Inc.

SPPINASDAQHealthcare
$1.03
$-0.01(-0.49%)
Market Cap$210377146
P/E Ratio
52W High$1.57
52W Low$0.32
Overview

Spectrum Pharmaceuticals, Inc. (SPPI) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · SPPI · as of Jun 9, 2026

Key Statistics

EPS (TTM)sppi eps ttm · sppi earnings per shareEarnings history
PE Ratio (TTM)sppi pe ratio ttm · sppi price to earningsPE Ratio deep dive
Revenue (TTM)sppi revenue ttm · sppi annual revenueFull revenue history
Dividend YieldNo Dividenddoes sppi pay dividends · sppi dividend yieldDividend history
Shares Outstandingsppi shares outstanding · sppi floatShares outstanding history
Next EarningsTBAsppi earnings date · sppi next earningsEarnings history

About Spectrum Pharmaceuticals, Inc.

CEOThomas J. Riga
IPO DateSep 26, 1996
Employees86
CountryUS
Websitesppirx.com

Spectrum Pharmaceuticals, Inc. operates as a biopharmaceutical firm, primarily engaged in the research, development, and market introduction of innovative drug products for cancer and blood disorders.…

what is spectrum pharmaceuticals, inc. · sppi stock overview · spectrum pharmaceuticals, inc. company profile · who is spectrum pharmaceuticals, inc. ceo · sppi NASDAQ · spectrum pharmaceuticals, inc. headquarters · spectrum pharmaceuticals, inc. business segments

About Stock Overview & Key Data

Spectrum Pharmaceuticals, Inc. (SPPI) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 26, 1996. As of the latest trading session, SPPI stock price is $1.02, with a market capitalization of $210.4M. The stock has returned — over the past 12 months and — year-to-date.

Frequently Asked Questions

As of the latest trading session, Spectrum Pharmaceuticals, Inc. (SPPI) stock price is $1.02. The stock is traded on NASDAQ under the ticker symbol SPPI. The 52-week range is $0.32 – $1.57.

SPPI stock priceSPPI quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice